New Qualified Person Oversight Regulations When Importing Investigational Medicinal Product to the UK, Upcoming Webinar Hosted by Xtalks
In this free webinar, the featured speakers will discuss the new requirements for importing finished investigational medicinal products (IMP) into Great Britain from an approved country. Attendees will learn about what documentation needs to be provided to the UK (IMP) holder providing the Qualified Person (QP) oversight service and how the documentation is used. Learn importer of record responsibilities and common associated shipping terminology and understand how Sharp can assist when importing to the UK following Brexit.
TORONTO, Feb. 15, 2022 /PRNewswire-PRWeb/ -- Qualified Person (QP) Oversight — Know how the new rules for importing finished investigational medicinal products (IMPs) into Great Britain from approved countries affects a clinical trial supply? As of January 1st, 2022, IMPs imported into Great Britain from approved countries (EU) will require a UK Manufacturing and Import Authorisation (MIA(IMP)) holder to have in place an assurance system to check that these IMPs have been certified by QP before release to the trial.
This webinar will describe:
- The importation routes available — direct to site or through a UK Distribution Hub
- The authorisations required by the UK MIA(IMP) holder and the clinical trial sponsor
- The assurance system required of the UK MIA(IMP) holder
- The trial documentation required by the UK (IMP) holder
- How Sharp provides the UK QP oversight of these imports
Importer of Record (IOR) — Know what importer record means and its responsibilities? How will a supply chain be affected with the new QP oversight regulations introduced? What changes has Brexit brought when importing to the UK?
Join experts from Sharp, Lisa Parkhouse, Quality Manager / QP; and Stewart Howells, Logistics Team Manager, for the live webinar on Wednesday, March 9, 2022 at 9:30am EST (2:30pm GMT/UK).
For more information, or to register for this event, visit New Qualified Person Oversight Regulations When Importing Investigational Medicinal Product to the UK.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Ayesha Rashid, Xtalks, +1 (416) 977-6555 x 272, [email protected]
SOURCE Xtalks
![](https://rt.prnewswire.com/rt.gif?NewsItemId=UN62113&Transmission_Id=202202150830PR_NEWS_USPR_____UN62113&DateId=20220215)
Share this article